glp-1 agonist moa and Anesthesia: Considerations and Cautions for CRNAs Recent updates on GLP-1 agonists:
Description
Foundayo and oral Wegovy have arrived
The current report aims to present an overview of current knowledge on GLP-1 RAs based on pragmatic review of the available clinical evidence
By Michael S
Novo Nordisk), which are glucagon-like peptide-1 receptor agonists (GLP-1Ra), have been sanctioned for prolonged weight management in people ...
Beyond these frontrunners, the pipeline is expanding: Novo Nordisk filed for FDA approval of CagriSema in 2025, the first once-weekly combination of GLP1 and amylin analogue
